[ET Net News Agency, 22 March 2024] FRONTAGE (01521) fell 3.9% to HK$1.49.
It hits an intra-day low of HK$1.49, hitting a historical low, and an intra-day high of
HK$1.56. The total shares traded was 828,000, with a value of HK$1.26m. The active
buy/sell ratio is 33:67, with net selling turnover of HK$417,360. GOLDMAN SACHS (ASIA) SEC
accounts for greatest net responsive buying turnover of HK$172,455, with volume weighted
average price of HK$1.52. CHINA INNOVATION MARKET SER accounts for greatest net responsive
selling turnover of HK$96,336, with volume weighted average price of HK$1.527. The stock
has fallen a combined 5.1% over the past 2 consecutive trading days.
Basic Information
=================
----------------------------------
Nominal 1.490 % Chg -3.87%
High 1.560 Low 1.490
Shares Tr 828,000 Turnover 1.26m
10-D SMA 1.566 %H.V 44.363
20-D SMA 1.600 VWAP 1.521
50-D SMA 1.747 RSI14 36.934
----------------------------------
Status: Hitting a historical low, active buy/sell ratio is 33:67, with net selling
turnover of HK$417,360, falling a combined 5.1% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
FRONTAGE (01521) 1.49 -3.87
HUTCHMED (00013) 25.75 -6.02
GENSCRIPT BIO (01548) 14.44 -6.96
INNOVENT BIO (01801) 35.10 -7.87
JXR (01951) 2.41 -5.86
EVEREST MED-B (01952) 24.40 -2.79
WUXI BIO (02269) 13.00 -8.45
BEIGENE (06160) 93.00 -8.19
AKESO (09926) 45.75 -3.89
REMEGEN (09995) 26.05 -6.13
---------------------------------------------
(ed)